EAST WINDSOR, N.J.--(BUSINESS WIRE)--NexMed, Inc. (Nasdaq: NEXM), a developer of innovative transdermal products based on its proprietary NexACT® drug delivery technology, today announced that Hem Pandya, Vice President and Chief Operating Officer, will present an overview of the Company at the Roth Capital 20th Annual OC Growth Stock Conference in Laguna Niguel, CA, at 4:30 pm Pacific Standard Time on Wednesday, February 20, 2008. The conference will feature interactive presentations from more than 300 selected companies in the Media, Technology, Telecommunications, Healthcare, Consumer, Energy, and Industrial sectors, in addition to one-on-one meetings with leading institutional investors.
